查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1734835

生理食鹽水市場至2032年的預測：按類型、容器類型、產量、應用、最終用途和地區的全球分析

Normal Saline for Parenteral Use Market Forecasts to 2032 - Global Analysis By Type (Plastic Bottles and Glass Bottles), Container Type, Volume, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的資料，全球生理食鹽水市場預計在2025年達到 36億美元，到2032年將達到 64億美元，預測期內的年複合成長率為 7.5%。

生理食鹽水是用於靜脈治療的無菌等滲溶液，其中含有 0.9%的氯化鈉。恢復體液平衡、維持血壓並在臨床環境中給藥。它在生理上等同於血漿，最大限度地減少輸注過程中的細胞損傷。生理食鹽水是緊急醫療、外科手術和脫水的基石，確保世界各地的醫院和救護車對患者照護。

根據美國國家生物技術資訊中心的資料，美國每年銷售約 2億公升生理食鹽水。此外，全球每天向患者注射超過一百萬公升0.9％的氯化鈉。

全球手術數量日益增加

全球範圍內外科手術數量的增加推動了對生理食鹽水重要靜脈注射液的需求。需要手術介入的慢性病盛行率不斷上升，推動著市場的成長。微創手術的進步增加了對可靠補水解決方案的需求。新興市場的醫療保健基礎設施不斷擴大將支持外科手術的增加。政府改善外科治療服務的措施將增加市場潛力。世界人口老化導致外科手術需求增加。

嚴格的監管要求

生理食鹽水的生產和分銷的嚴格規定增加了合規成本。製造設施的核准流程複雜，阻礙了市場進入。嚴格的品管標準需要大量的技術投資。不同地區有不同的規定，這使得全球供應鏈變得複雜。違規可能會導致產品召回並損害品牌聲譽。配方調整的彈性有限阻礙了創新。

開發創新包裝解決方案

包裝方面的創新，例如環保和防篡改設計，為市場擴張創造機會。先進的包裝可提高產品安全性、保存期限並吸引醫療保健提供者。人們對攜帶式、易於生理食鹽水輸送系統的需求日益增加。與包裝技術公司的合作加速了產品開發。對永續包裝的監管支持推動了投資。一次性無菌包裝的趨勢將增加市場吸引力。這些進步將提高不同醫療保健環境中的可近性和採用率。

原物料價格波動

氯化鈉、無菌水等原物料價格的波動影響生產成本。供應鏈中斷將加劇價格波動並影響盈利。對有限數量供應商的依賴增加了對市場衝擊的脆弱性。滅菌過程的能源成本上升增加了財務負擔。不可預測的定價使與醫療保健提供者的長期合約變得複雜。缺乏多樣化的籌資策略會增加風險。

COVID-19的影響：

由於住院人數和重症患者人數增加， COVID-19 疫情導致生理食鹽水需求激增。供應鏈中斷導致原料交付延遲，影響生產。隨著遠端醫療的增加，生理食鹽水減少。然而，疫苗接種宣傳活動和醫療緊急情況刺激了市場需求。疫情期間生產成本上升影響了人們的負擔能力。這場疫情凸顯了可靠輸注的重要性，並為投資提供了動力。預計疫情過後外科手術的復甦將維持市場成長。

預計塑膠瓶領域在預測期內將佔據最大佔有率

由於塑膠瓶在醫院中廣泛用於安全、便捷地供應生理食鹽水，預計在預測期內將佔據最大的市場佔有率。塑膠瓶具有耐用性且易於操作，可提高業務效率。無菌製造技術的進步確保了產品的安全性和合規性。塑膠瓶的成本效益將推動其在注重預算的市場中的應用。醫用塑膠的監管核准增強市場信心。它在外科手術和急救應用中的多功能性將增強市場佔有率。

預計在預測期內，軟袋領域將出現最高的年複合成長率。

由於其輕量化設計和在醫療保健環境中節省空間的優勢，預計軟性袋領域將在預測期內實現最高的成長率。軟性袋降低了儲存和運輸成本，因此對醫院很有吸引力。防篡改和環保袋設計的創新將會增加其採用率。由於門診病人和居家醫療的增加，對攜帶式生理食鹽水的需求也在增加。對永續包裝的監管支持有助於推動該領域的擴張。與物流公司合作可以最佳化配送效率。關注患者的便利性將推動這一領域的成長。

佔比最高的地區：

預計亞太地區將在預測期內佔據最大的市場佔有率。這是因為中國和印度等國家擁有強大的醫療保健產業和大量的手術。人口的快速成長和慢性疾病的增加推動對生理食鹽水的需求。政府對醫療保健基礎設施的投資支持市場成長。主要製造商的存在增強了區域主導地位。外科手術治療機會的增加推動了生理食鹽水的使用。可支配收入的增加推動了醫療保健支出。

年複合成長率最高的地區：

在預測期內，北美預計將因其先進的醫療保健體系和嚴格的監管標準而呈現最高的年複合成長率。該地區的手術率很高，對可靠生理食鹽水的需求不斷成長。包裝和運輸系統的創新將推動市場成長。大型製藥公司的存在推動了產品開發。患者安全意識的增強推動其採用。對門診護理基礎設施的投資將支持擴張。

免費客製化服務：

訂閱此報告的客戶可享有以下免費自訂選項之1：

  • 公司簡介
    • 全面分析其他市場參與者（最多3家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章 市場走勢分析

  • 促進因素
  • 限制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭敵對

第5章 全球生理食鹽水市場（依類型）

  • 寶特瓶
  • 玻璃瓶

第6章 全球生理食鹽水市場（依容器類型）

  • 軟包
  • 硬質瓶子和容器
  • 預填充式注射器
  • 點滴瓶
  • 管瓶
  • 安瓿
  • 其他容器類型

第7章 全球生理食鹽水市場（依數量）

  • 小容量非經口給藥（SVP）
  • 大容量非經口給藥（LVP）
  • 其他卷

第8章 全球生理食鹽水市場（依應用）

  • 肌肉注射
  • 靜脈注射
  • 傷口清洗/沖洗

第9章 全球生理食鹽水市場（依最終用戶）

  • 醫院
  • 專科診所
  • 門診手術中心
  • 其他最終用戶

第10章 全球生理食鹽水市場（依地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Baxter
  • Pfizer
  • B. Braun
  • ICU Medical
  • Fresenius Kabi
  • Otsuka
  • Kelun Group
  • CR Double-Cran
  • SSY Group
  • Cisen Pharmaceutical
  • Denis Chem Lab Limited
  • Advacare Pharma USA, LLC.
  • NIRMA LIMITED
  • Alcare pharmaceuticals pte ltd
  • Sichuan Kelun Pharmaceutical Co., Ltd.
Product Code: SMRC29472

According to Stratistics MRC, the Global Normal Saline for Parenteral Use Market is accounted for $3.6 billion in 2025 and is expected to reach $6.4 billion by 2032 growing at a CAGR of 7.5% during the forecast period. Normal Saline for Parenteral Use is a sterile, isotonic solution of 0.9% sodium chloride in water, used for intravenous (IV) therapy. It restores fluid balance, maintains blood pressure, and delivers medications in clinical settings. As a physiological equivalent to blood plasma, it minimizes cellular damage during infusion. Normal saline is a cornerstone of emergency medicine, surgery, and dehydration treatment, ensuring safe and effective patient care in hospitals and ambulances worldwide.

According to the National Center for Biotechnology Information, in the U.S., around 200 million liters of saline are sold annually. In addition, over 1 million liters of 0.9% sodium chloride are administered to patients across the globe daily.

Market Dynamics:

Driver:

Increasing surgical procedures globally

The rising number of surgical procedures worldwide is fueling demand for normal saline as a critical intravenous fluid. Growing prevalence of chronic diseases requiring surgical interventions drives market growth. Advancements in minimally invasive surgeries increase the need for reliable hydration solutions. Expanding healthcare infrastructure in emerging markets supports higher surgical volumes. Government initiatives to improve access to surgical care enhance market potential. The aging global population contributes to increased surgical needs.

Restraint:

Stringent regulatory requirements

Stringent regulations governing the production and distribution of parenteral saline solutions increase compliance costs. Complex approval processes for manufacturing facilities delay market entry. Strict quality control standards require significant investment in technology. Regulatory variations across regions complicate global supply chains. Non-compliance risks product recalls, damaging brand reputation. Limited flexibility in formulation adjustments hinders innovation.

Opportunity:

Development of innovative packaging solutions

Innovations in packaging, such as eco-friendly and tamper-proof designs, are creating opportunities for market expansion. Advanced packaging enhances product safety and shelf life, appealing to healthcare providers. The demand for portable and user-friendly saline delivery systems is rising. Partnerships with packaging technology firms drive product development. Regulatory support for sustainable packaging encourages investment. The trend toward single-use, sterile packaging boosts market appeal. These advancements improve accessibility and adoption in diverse healthcare settings.

Threat:

Raw material price fluctuations

Fluctuations in the prices of raw materials, such as sodium chloride and sterile water, impact production costs. Supply chain disruptions exacerbate price volatility, affecting profitability. Dependence on limited suppliers increases vulnerability to market shocks. Rising energy costs for sterilization processes add financial strain. Unpredictable pricing complicates long-term contracts with healthcare providers. Lack of diversified sourcing strategies heightens risks.

Covid-19 Impact:

The COVID-19 pandemic surged demand for normal saline due to increased hospitalizations and critical care needs. Supply chain disruptions delayed raw material deliveries, impacting production. The rise in telehealth reduced non-emergency saline use in outpatient settings. However, vaccination campaigns and emergency care boosted market demand. Rising manufacturing costs during the crisis affected affordability. The pandemic underscored the importance of reliable IV fluids, driving investments. Post-pandemic recovery in surgical procedures is expected to sustain market growth.

The plastic bottles segment is expected to be the largest during the forecast period

The plastic Bottles segment is expected to account for the largest market share during the forecast period propelled by their widespread use in hospitals for safe and convenient saline delivery. Plastic bottles offer durability and ease of handling, enhancing operational efficiency. Advances in sterile manufacturing ensure product safety and compliance. The cost-effectiveness of plastic bottles drives adoption in budget-conscious markets. Regulatory approvals for medical-grade plastics bolster market trust. Their versatility across surgical and emergency applications strengthens market share.

The flexible bags segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the flexible bags segment is predicted to witness the highest growth rate driven by their lightweight design and space-saving benefits in healthcare settings. Flexible bags reduce storage and transportation costs, appealing to hospitals. Innovations in tamper-proof and eco-friendly bag designs enhance adoption. The rise in outpatient and home care increases demand for portable saline solutions. Regulatory support for sustainable packaging fuels segment expansion. Partnerships with logistics firms optimize distribution efficiency. The focus on patient convenience propels this segment's growth.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share owing to its robust healthcare sector and high surgical volumes in countries like China and India. Rapid population growth and rising chronic diseases drive demand for saline. Government investments in healthcare infrastructure support market growth. The presence of key manufacturers strengthens regional dominance. Increasing access to surgical care fuels saline use. Rising disposable incomes enhance healthcare spending.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR fueled by advanced healthcare systems and stringent regulatory standards. The region's high surgical procedure rates drive demand for reliable saline solutions. Innovations in packaging and delivery systems enhance market growth. The presence of leading pharmaceutical companies fosters product development. Growing awareness of patient safety boosts adoption. Investments in outpatient care infrastructure support expansion.

Key players in the market

Some of the key players in Normal Saline for Parenteral Use Market include Baxter, Pfizer, B. Braun, ICU Medical, Fresenius Kabi, Otsuka, Kelun Group, CR Double-Cran, SSY Group, Cisen Pharmaceutical, Denis Chem Lab Limited, Advacare Pharma USA, LLC., NIRMA LIMITED, Alcare Pharmaceuticals Pte Ltd, and Sichuan Kelun Pharmaceutical Co., Ltd.

Key Developments:

In April 2025, Baxter International expanded production of FDA-approved electrolyte-enriched saline solutions with improved stability for critical care, addressing global IV fluid shortages in emergency medicine.

In March 2025, Fresenius Kabi launched premixed saline bags with pH-balancing additives for chemotherapy patients, reducing side effects and simplifying oncology infusion protocols in hospitals.

In February 2025, Kelun Group debuted China's first biodegradable saline IV packaging, cutting plastic waste by 70% while maintaining sterility standards for large-volume parenteral therapies.

Types Covered:

  • Plastic Bottles
  • Glass Bottles

Container Types Covered:

  • Flexible Bags
  • Rigid Bottles And Containers
  • Pre-Filled Syringes
  • IV Infusion Bottles
  • Vials
  • Ampoules
  • Other Container Types

Volumes Covered:

  • Small Volume Parenteral (SVP)
  • Large Volume Parenteral (LVP)
  • Other Volumes

Applications Covered:

  • Intramuscular Injection
  • Intravenous Injection
  • Wound Irrigation/Flush

End Users Covered:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Normal Saline for Parenteral Use Market, By Type

  • 5.1 Introduction
  • 5.2 Plastic Bottles
  • 5.3 Glass Bottles

6 Global Normal Saline for Parenteral Use Market, By Container Type

  • 6.1 Introduction
  • 6.2 Flexible Bags
  • 6.3 Rigid Bottles And Containers
  • 6.4 Pre-Filled Syringes
  • 6.5 IV Infusion Bottles
  • 6.6 Vials
  • 6.7 Ampoules
  • 6.8 Other Container Types

7 Global Normal Saline for Parenteral Use Market, By Volume

  • 7.1 Introduction
  • 7.2 Small Volume Parenteral (SVP)
  • 7.3 Large Volume Parenteral (LVP)
  • 7.4 Other Volumes

8 Global Normal Saline for Parenteral Use Market, By Application

  • 8.1 Introduction
  • 8.2 Intramuscular Injection
  • 8.3 Intravenous Injection
  • 8.4 Wound Irrigation/Flush

9 Global Normal Saline for Parenteral Use Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Specialty Clinics
  • 9.4 Ambulatory Surgical Centers
  • 9.5 Other End Users

10 Global Normal Saline for Parenteral Use Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Baxter
  • 12.2 Pfizer
  • 12.3 B. Braun
  • 12.4 ICU Medical
  • 12.5 Fresenius Kabi
  • 12.6 Otsuka
  • 12.7 Kelun Group
  • 12.8 CR Double-Cran
  • 12.9 SSY Group
  • 12.10 Cisen Pharmaceutical
  • 12.11 Denis Chem Lab Limited
  • 12.12 Advacare Pharma USA, LLC.
  • 12.13 NIRMA LIMITED
  • 12.14 Alcare pharmaceuticals pte ltd
  • 12.15 Sichuan Kelun Pharmaceutical Co., Ltd.

List of Tables

  • Table 1 Global Normal Saline for Parenteral Use Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Normal Saline for Parenteral Use Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Normal Saline for Parenteral Use Market Outlook, By Plastic Bottles (2024-2032) ($MN)
  • Table 4 Global Normal Saline for Parenteral Use Market Outlook, By Glass Bottles (2024-2032) ($MN)
  • Table 5 Global Normal Saline for Parenteral Use Market Outlook, By Container Type (2024-2032) ($MN)
  • Table 6 Global Normal Saline for Parenteral Use Market Outlook, By Flexible Bags (2024-2032) ($MN)
  • Table 7 Global Normal Saline for Parenteral Use Market Outlook, By Rigid Bottles And Containers (2024-2032) ($MN)
  • Table 8 Global Normal Saline for Parenteral Use Market Outlook, By Pre-Filled Syringes (2024-2032) ($MN)
  • Table 9 Global Normal Saline for Parenteral Use Market Outlook, By IV Infusion Bottles (2024-2032) ($MN)
  • Table 10 Global Normal Saline for Parenteral Use Market Outlook, By Vials (2024-2032) ($MN)
  • Table 11 Global Normal Saline for Parenteral Use Market Outlook, By Ampoules (2024-2032) ($MN)
  • Table 12 Global Normal Saline for Parenteral Use Market Outlook, By Other Container Types (2024-2032) ($MN)
  • Table 13 Global Normal Saline for Parenteral Use Market Outlook, By Volume (2024-2032) ($MN)
  • Table 14 Global Normal Saline for Parenteral Use Market Outlook, By Small Volume Parenteral (SVP) (2024-2032) ($MN)
  • Table 15 Global Normal Saline for Parenteral Use Market Outlook, By Large Volume Parenteral (LVP) (2024-2032) ($MN)
  • Table 16 Global Normal Saline for Parenteral Use Market Outlook, By Other Volumes (2024-2032) ($MN)
  • Table 17 Global Normal Saline for Parenteral Use Market Outlook, By Application (2024-2032) ($MN)
  • Table 18 Global Normal Saline for Parenteral Use Market Outlook, By Intramuscular Injection (2024-2032) ($MN)
  • Table 19 Global Normal Saline for Parenteral Use Market Outlook, By Intravenous Injection (2024-2032) ($MN)
  • Table 20 Global Normal Saline for Parenteral Use Market Outlook, By Wound Irrigation/Flush (2024-2032) ($MN)
  • Table 21 Global Normal Saline for Parenteral Use Market Outlook, By End User (2024-2032) ($MN)
  • Table 22 Global Normal Saline for Parenteral Use Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 23 Global Normal Saline for Parenteral Use Market Outlook, By Specialty Clinics (2024-2032) ($MN)
  • Table 24 Global Normal Saline for Parenteral Use Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 25 Global Normal Saline for Parenteral Use Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.